Nadine Ezard

2.6k total citations · 1 hit paper
93 papers, 1.7k citations indexed

About

Nadine Ezard is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Nadine Ezard has authored 93 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Epidemiology, 26 papers in Public Health, Environmental and Occupational Health and 25 papers in General Health Professions. Recurrent topics in Nadine Ezard's work include Substance Abuse Treatment and Outcomes (26 papers), HIV, Drug Use, Sexual Risk (22 papers) and Opioid Use Disorder Treatment (20 papers). Nadine Ezard is often cited by papers focused on Substance Abuse Treatment and Outcomes (26 papers), HIV, Drug Use, Sexual Risk (22 papers) and Opioid Use Disorder Treatment (20 papers). Nadine Ezard collaborates with scholars based in Australia, United Kingdom and United States. Nadine Ezard's co-authors include Nicholas Lintzeris, Krista J. Siefried, Monica J. Barratt, Adrian Dunlop, Lisa Maher, Raimondo Bruno, Paul Haber, Michelle Hall, John Ryan and Peter Saul and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

Nadine Ezard

74 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic

2020 202 citations Adrian Dunlop, Michelle Hall et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nadine Ezard Australia	20	723	441	394	381	260	93	1.7k
Rebecca Jenkinson Australia	26	922 1.3×	228 0.5×	494 1.3×	279 0.7×	229 0.9×	51	1.6k
Masoumeh Amin‐Esmaeili Iran	23	715 1.0×	435 1.0×	392 1.0×	220 0.6×	191 0.7×	89	1.7k
Eamon Keenan Ireland	23	1000 1.4×	153 0.3×	525 1.3×	233 0.6×	224 0.9×	95	1.6k
Afarin Rahimi‐Movaghar Iran	29	1.4k 2.0×	760 1.7×	971 2.5×	427 1.1×	302 1.2×	147	3.2k
Alireza Noroozi Iran	22	785 1.1×	182 0.4×	354 0.9×	143 0.4×	114 0.4×	107	1.4k
Adrian Dunlop Australia	26	1.4k 1.9×	307 0.7×	1.1k 2.7×	486 1.3×	357 1.4×	167	2.7k
M. Teresa Brugal Spain	29	1.8k 2.5×	272 0.6×	1.0k 2.6×	473 1.2×	214 0.8×	130	2.8k
M. Eugenia Socías Canada	30	1.3k 1.7×	285 0.6×	920 2.3×	340 0.9×	151 0.6×	145	2.8k
Craig Fry Australia	26	1.1k 1.5×	223 0.5×	984 2.5×	527 1.4×	94 0.4×	86	2.2k
Joan Colom Spain	23	811 1.1×	214 0.5×	189 0.5×	395 1.0×	233 0.9×	116	1.6k

Countries citing papers authored by Nadine Ezard

Since Specialization

Citations

This map shows the geographic impact of Nadine Ezard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadine Ezard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadine Ezard more than expected).

Fields of papers citing papers by Nadine Ezard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadine Ezard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadine Ezard. The network helps show where Nadine Ezard may publish in the future.

Co-authorship network of co-authors of Nadine Ezard

This figure shows the co-authorship network connecting the top 25 collaborators of Nadine Ezard. A scholar is included among the top collaborators of Nadine Ezard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadine Ezard. Nadine Ezard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiao, Bo, Krista J. Siefried, Nadine Ezard, et al.. (2025). Exploring experiences of talk therapies among gay and bisexual men seeking to reduce or abstain from using crystal methamphetamine in the context of chemsex. Drug and Alcohol Review. 44(3). 711–722. 3 indexed citations

Siefried, Krista J., Amy Peacock, Michael J. Barratt, et al.. (2025). From environmental disasters to emerging drugs; a framework to understand, map and assess drug-related early warning systems. International Journal of Drug Policy. 145. 104946–104946.

Ritter, Alison, James Bell, John Strang, et al.. (2025). Bridging the evidence and the politics: Implementation trial of supervised injectable opioid treatment (SIOT) in Australia. International Journal of Drug Policy. 138. 104749–104749.

Siefried, Krista J., Janette L. Smith, Jared A Brown, et al.. (2025). Emergency department presentations, hospitalisations and police seizure data related to gamma‐hydroxybutyrate (GHB) in New South Wales, Australia, from 2015 to 2024. Addiction. 121(2). 305–315.

Smith, Jennifer L., Courtney Weber, Jennifer Schumann, et al.. (2025). Novel psychoactive substances in Australian emergency departments: implications for public health practice from multi-centre prospective toxicosurveillance across five states, 2022–2023. International Journal of Drug Policy. 145. 104969–104969.

Carland, Jane E., et al.. (2025). A 3-year experience of an Australian short-stay Psychiatric, Alcohol and Non-prescription Drug Assessment Unit: unit activity and the patient experience. Emergency Medicine Journal. 43(1). 15–21.

Smith, Jennifer L., Shaun L. Greene, Courtney Weber, et al.. (2024). A multicentre case series of analytically confirmed gamma‐hydroxybutyrate intoxications in Western Australian emergency departments: Pre‐hospital circumstances, co‐detections and clinical outcomes. Drug and Alcohol Review. 43(4). 984–996. 4 indexed citations

Fatovich, Daniel M, et al.. (2024). ‘You mean you're not doing it already?’ A national sentinel toxico‐surveillance system for detecting illicit, emerging and novel psychoactive drugs in presentations to emergency departments. Emergency Medicine Australasia. 36(6). 990–992. 1 indexed citations

Black, Eleanor, Emma Black, Apo Demirkol, et al.. (2024). Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, Australia. Journal of Addiction Medicine. 18(6). 619–627.

10.

Ezard, Nadine, Krista J. Siefried, Robert Ali, et al.. (2024). Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo‐controlled trial. Addiction. 120(7). 1345–1359. 2 indexed citations

11.

Siefried, Krista J., et al.. (2023). “There’s a big tag on my head”: exploring barriers to treatment seeking with women who use methamphetamine in Sydney, Australia. BMC Health Services Research. 23(1). 162–162. 10 indexed citations

12.

Sharafi, Heidar, Sarah Drouin, Stephanie Coronado‐Montoya, et al.. (2023). Prescription psychostimulants for the treatment of amphetamine‐type stimulant use disorder: A systematic review and meta‐analysis of randomized placebo‐controlled trials. Addiction. 119(2). 211–224. 9 indexed citations

13.

Sharafi, Heidar, Arash Bahremand, Sarah Drouin, et al.. (2023). Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trials. Drug and Alcohol Dependence. 253. 111018–111018. 3 indexed citations

14.

Ezard, Nadine, Nicholas Lintzeris, Adrian Dunlop, et al.. (2022). Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial. Drug and Alcohol Dependence. 241. 109692–109692. 10 indexed citations

15.

Black, Emma, Rachel Deacon, Nadine Ezard, et al.. (2022). Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016–2019. Drug and Alcohol Review. 42(2). 389–400. 2 indexed citations

16.

Smith, Jennifer L., Andrew Dawson, Sam Alfred, et al.. (2021). The Emerging Drugs Network of Australia: A toxicosurveillance system of illicit and emerging drugs in the emergency department. Emergency Medicine Australasia. 34(1). 58–64. 26 indexed citations

17.

Peacock, Amy, Monica J. Barratt, Raimondo Bruno, et al.. (2019). Engagement in drug checking ('pill testing') and behavioural responses by people who use drugs in Australia. UNSWorks (University of New South Wales, Sydney, Australia). 2 indexed citations

18.

Ezard, Nadine, Beatrice Webb, Toby Lea, et al.. (2018). Substance Use and Sex Index (SUSI): First stage development of an assessment tool to measure behaviour change in sexualised drug use for substance use treatment studies. International Journal of Drug Policy. 55. 165–168. 2 indexed citations

19.

Barratt, Monica J., Raimondo Bruno, Nadine Ezard, & Alison Ritter. (2017). Pill testing or drug checking in Australia: Acceptability of service design features. Drug and Alcohol Review. 37(2). 226–236. 68 indexed citations

20.

Iversen, Jenny, Kate Dolan, Nadine Ezard, & Lisa Maher. (2015). HIV and Hepatitis C Virus Infection and Risk Behaviors Among Heterosexual, Bisexual, and Lesbian Women Who Inject Drugs in Australia. LGBT Health. 2(2). 127–134. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact